Our Providers

Srilaxmi Bearelly, MD, MHS
  • Assistant Professor of Ophthalmology at CUMC
Srilaxmi Bearelly, <span>MD, MHS</span>

Dr. Srilaxmi Bearelly is a nationally recognized ophthalmologist specializing in macular degeneration, diabetic retinopathy, retinal vascular occlusions, choroidal neovascularization and macular disorders. Her research interests include retinal imaging of age-related macular degeneration and diabetic retinopathy.

Dr. Bearelly graduated from Northwestern University with a B.A. in Biology, received her M.D. from Northwestern University Medical School, as well as a Masters of Health Sciences from Duke University School of Medicine. Following her ophthalmology training at Northwestern University, she completed her fellowship training in diseases of the retina and vitreous at Duke University Eye Center.

She is listed as one of “America’s Top Ophthalmologists” by Consumers’ Research Council of America. She received several research awards, including an NIH/NEI K12 Mentored Research Career Award, NIH/NEI K23 Mentored Research Career Award, and a Young Investigator Award by Retinal Degenerations Symposium at the International Congress of Eye Research Meeting in China.

Dr. Bearelly’s primary research interests are in age-related macular degeneration and diabetic retinopathy. Currently she is studying imaging technologies to predict progression of age-related macular degeneration. The emergence of many new clinical trials evaluating therapies for macular degeneration has increased the need for reliable and accurate means of monitoring and predicting macular degeneration progression. Imaging markers could help to stratify slow and fast progressors, thus expediting the evaluation of new therapies.

Dr. Bearelly is interested in approaching scientific questions from a patient perspective. Her long-term career goal is to design and implement early, innovative phase I and II clinical trials by applying advancements in the basic sciences. The potential for public health impact is enormous, as prevalence of macular degeneration is expected to double by 2030, and the prevalence of diabetic retinopathy is expected to triple by 2050. Novel approaches to treatment are needed for both of these diseases.

Board Certifications

  • Ophthalmology

Areas of Expertise

  • Retinal Disorders
  • Macular Degeneration
  • Vitreoretinal Disorder
  • Intravitreal Injection
  • Retinal Vascular Occlusion
  • Laser Treatment
  • Retinal Disease
  • Diabetic Retinopathy

    Education & Training

  • Northwestern University Medical School
  • Residency: Northwestern University Medical School
  • Fellowship: Duke University Medical Center, NC


  • Edward S. Harkness Eye Institute

    635 West 165th Street
    Floor: 5
    New York, NY 10032
    For new and current patient appointments, call:
    (212) 305-9535
    (212) 342-5293
  • CUMC/Russ Berrie Medical Science Pavilion

    1150 St. Nicholas Avenue
    New York, NY 10032
    For new and current patient appointments, call:
    (212) 851-5494
    (212) 851-5493

Provider Affiliations

  • NewYork-Presbyterian/Columbia

Insurance Programs

Please contact the provider's office directly to verify that your particular insurance is accepted.

  • Aetna [EPO, HMO, Medicare Managed Care, NY Signature, NYP Employee Plan, POS, PPO, Signature Administrators, Student Health]
  • Amida Care [Special Needs Plan]
  • Cigna [EPO, Great West, HMO, POS, PPO]
  • Emblem/GHI [Medicare Managed Care, PPO]
  • Emblem/HIP [ConnectiCare, EPO, Essential Plan, HMO, Medicaid Managed Care, Medicare Managed Care, POS, PPO, Select Care (Exchange), Vytra]
  • Empire Blue Cross Blue Shield [Blue Access (Exchange), EPO, Gatekeeper (Exchange), HMO, Medicare Managed Care, Pathway (Exchange), POS, PPO]
  • MagnaCare [MagnaCare]
  • Medicare [Traditional Medicare (NY)]
  • Multiplan [Multiplan]
  • Oxford Health Plans [Freedom, Liberty, Medicare Managed Care]
  • UnitedHealthcare [Columbia University Employee Plan, Compass (Exchange), Essential Plan, HMO, Medicaid (Community Plan), Medicare Managed Care, POS, PPO]
  • VNSNY CHOICE [Medicare Managed Care]
  • WellCare [Medicaid Managed Care, Medicare Managed Care]

This provider accepts new patients

Appointment Phone Number: (212) 305-9535

Honors & Awards

  • 2012-present Robert L. Burch III Scholar, Columbia University
  • 2011 Irving Institute for Clinical and Translational Research: Reach for the First R01 Course, TRANSFORM program
  • 2005-2010 NIH/NEI K12 and K23 Mentored Career Development Awards
  • 2009-present Listed as one of “America’s Top Ophthalmologists” by Consumers’ Research Council of America
  • 2008 Young Investigator Award, Retinal Degenerations/International   Congress of Eye Research
  • 1999 Resident Teaching Award, Department of Internal Medicine at Northwestern University: Excellence in Teaching of Medical Students
  • 1992-1999 Honors Program in Medical Education (HPME), Northwestern University BA/M.D. Program
  • 1998 American Association for Higher Education Research Grant, Department of Physiology at Northwestern University: Program for Excellence in Teaching
  • 1992-1995 Northwestern University Academic Grants
  • 1992-1993 Robert C. Byrd Scholarship, ASTRA Scholarship

Research Interests

  • Novel imaging and serum biomarkers in age-related macular degeneration, diabetic retinopathy
  • Innovative clinical studies in vitreoretinal disease

NIH Grants


    Aug 1 2011 - Jul 31 2017


  • Bearelly S, Espinosa-Heidmann DG, Cousins SW.  The role of dynamic indocyanine green angiography in the diagnosis and treatment of retinal angiomatous proliferation. Br J Ophthalmol  2008; 92(2): 191-6. 2013, April 29.  Epub ahead of print.
  • Xu L, Blonska AM, Pumariega NM, Bearelly S, Sohrab MA, Hageman GS, Smith RT. Reticular macular disease is associated with multilobular geographic atrophy in age-related macular degeneration. Retina 2013. Epub ahead of print.
  • Martillo MA, Marsiglia M, Lee MD, Pumariega N, Bearelly S, Smith RT.  Is reticular macular disease a choriocapillaris perfusion problem?  Medical Hypothesis, Discovery, and Innovation: Ophthalmology Journal 2012; 1(2): 37-39.
  • Khanifar AA, Lederer DE, Ghodasra JH, Stinnett SS, Lee JJ, Cousins SW, Bearelly S. Comparison of color fundus photographs and fundus autofluorescence images in measuring geographic atrophy area.  Retina 2012; 32(9):1884-91. PMID: 22547167.
  • Bearelly S, Khanifar AA, Lederer DE, Lee JJ, Ghodasra JH, Stinnett SS, Cousins SW. Use of fundus autofluorescence images to predict geographic atrophy progression. Retina 2011; 31(1):81-6. PMC ID: PMC3040508.
  • Jain N, Farsiu S, Khanifar A, Bearelly S, Smith RT, Izatt J, Toth C.  Quantitative comparison of drusen segmented on SDOCT versus drusen delineated on color fundusphotographs.  Invest Ophthalmol Vis Sci. 2010; 51(10):4875-83. PMC ID: PMC2939301.
  • Bearelly S, Chau FY, Koreishi A, Stinnett SS, Izatt J, Toth CA.  Spectral domain optical coherence tomography (SDOCT) imaging of geographic atrophy margins. Ophthalmology 2009; 116(9):1762-9.  PMCID:  PMC2738753.
  • Garg S, Mets M, Bearelly S, Mets R.  Imaging of congenital toxoplasmosis macular scars with optical coherence tomography.  Retina 2009; 29(5):631-7.
  • Cousins SW, Bearelly S, Reinoso MA, Chi SL, Espinosa-Heidmann D.  Dynamic indocyanine green angiography-guided focal thermal laser treatment of fibrotic choroidal neovascularization. Graefe’s Arch Clin Exp Ophthalmol 2008; 246(12):1677
  • Bearelly S,  Mruthyunjaya P, Tzeng JP, Suner IJ, Shea AM, Lee JT, Kowalski JW, Curtis LH, Schulman KA, Lee PP.  Identification of patients with diabetic macular edema   from claims data:  a validation study.  Arch Ophthalmol 2008; 126(7): 986-9.
  • Ahmed S, Bearelly S, Stinnett SS, Cooney MJ, Fekrat S.  Photodynamic therapy for predominantly hemorrhagic lesions in neovascular age-related macular degeneration. Am J Ophthalmol 2008;  145(6):1052-7.